FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007083491> ?p ?o ?g. }

• W2007083491 endingPage "108" @default.
• W2007083491 startingPage "102" @default.
• W2007083491 abstract "Thai soldiers were vaccinated with a recombinant protein derived from the central repeat region of the circumsporozoite (CS) protein of Plasmodium falciparum conjugated to Toxin A (detoxified) of Pseudomonas aeruginosa (R32Tox-A) to evaluate its safety, immunogenicity and efficacy. In a randomized, double-blind manner, 199 volunteers received either R32Tox-A or a control vaccine at 0, 8 and 16 weeks. Immunization was performed in a malaria non-transmission area, after completion of which volunteers were deployed to an endemic border area and monitored closely to allow early detection and treatment of infection. The vaccine was found to be safe and to elicit antibody responses in all vaccinees. Peak CS antibody (IgG) concentrations in malaria-experienced vaccinees exceeded those in malaria-naive vaccinees (mean 40.6 versus 16.1 micrograms ml-1; p = 0.005) as well as those induced by previous CS protein-derived vaccines and observed in association with natural infections. A log-rank comparison of time to falciparum malaria revealed no differences between vaccinated and non-vaccinated subjects. Secondary analyses revealed that CS antibody levels were lower in vaccinee malaria cases than in non-cases, 3 and 5 months after the third dose of vaccine (p = 0.06 and p = 0.014, respectively). Because antibody levels had fallen substantially before peak malaria transmission occurred, the question of whether high levels of CS antibody are protective remains to be resolved." @default.
• W2007083491 created "2016-06-24" @default.
• W2007083491 creator A5003985570 @default.
• W2007083491 creator A5006161820 @default.
• W2007083491 creator A5013478988 @default.
• W2007083491 creator A5015314211 @default.
• W2007083491 creator A5019521007 @default.
• W2007083491 creator A5029140541 @default.
• W2007083491 creator A5032362185 @default.
• W2007083491 creator A5034781292 @default.
• W2007083491 creator A5034787615 @default.
• W2007083491 creator A5044663027 @default.
• W2007083491 creator A5052885960 @default.
• W2007083491 creator A5054295025 @default.
• W2007083491 creator A5058079190 @default.
• W2007083491 creator A5063342340 @default.
• W2007083491 creator A5065117229 @default.
• W2007083491 creator A5069829374 @default.
• W2007083491 creator A5070598850 @default.
• W2007083491 creator A5088105178 @default.
• W2007083491 date "1994-01-01" @default.
• W2007083491 modified "2023-10-09" @default.
• W2007083491 title "Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers" @default.
• W2007083491 cites W1871729670 @default.
• W2007083491 cites W2002568336 @default.
• W2007083491 cites W2006364385 @default.
• W2007083491 cites W2031653118 @default.
• W2007083491 cites W2053948426 @default.
• W2007083491 cites W2062032776 @default.
• W2007083491 cites W2063122125 @default.
• W2007083491 cites W2072199382 @default.
• W2007083491 cites W2072375525 @default.
• W2007083491 cites W2084250742 @default.
• W2007083491 cites W2120000058 @default.
• W2007083491 cites W2144523774 @default.
• W2007083491 cites W2400815690 @default.
• W2007083491 cites W2411440147 @default.
• W2007083491 doi "https://doi.org/10.1016/0264-410x(94)90046-9" @default.
• W2007083491 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8147091" @default.
• W2007083491 hasPublicationYear "1994" @default.
• W2007083491 type Work @default.
• W2007083491 sameAs 2007083491 @default.
• W2007083491 citedByCount "42" @default.
• W2007083491 countsByYear W20070834912013 @default.
• W2007083491 countsByYear W20070834912014 @default.
• W2007083491 countsByYear W20070834912015 @default.
• W2007083491 countsByYear W20070834912016 @default.
• W2007083491 countsByYear W20070834912019 @default.
• W2007083491 crossrefType "journal-article" @default.
• W2007083491 hasAuthorship W2007083491A5003985570 @default.
• W2007083491 hasAuthorship W2007083491A5006161820 @default.
• W2007083491 hasAuthorship W2007083491A5013478988 @default.
• W2007083491 hasAuthorship W2007083491A5015314211 @default.
• W2007083491 hasAuthorship W2007083491A5019521007 @default.
• W2007083491 hasAuthorship W2007083491A5029140541 @default.
• W2007083491 hasAuthorship W2007083491A5032362185 @default.
• W2007083491 hasAuthorship W2007083491A5034781292 @default.
• W2007083491 hasAuthorship W2007083491A5034787615 @default.
• W2007083491 hasAuthorship W2007083491A5044663027 @default.
• W2007083491 hasAuthorship W2007083491A5052885960 @default.
• W2007083491 hasAuthorship W2007083491A5054295025 @default.
• W2007083491 hasAuthorship W2007083491A5058079190 @default.
• W2007083491 hasAuthorship W2007083491A5063342340 @default.
• W2007083491 hasAuthorship W2007083491A5065117229 @default.
• W2007083491 hasAuthorship W2007083491A5069829374 @default.
• W2007083491 hasAuthorship W2007083491A5070598850 @default.
• W2007083491 hasAuthorship W2007083491A5088105178 @default.
• W2007083491 hasConcept C159047783 @default.
• W2007083491 hasConcept C159654299 @default.
• W2007083491 hasConcept C203014093 @default.
• W2007083491 hasConcept C22070199 @default.
• W2007083491 hasConcept C2778048844 @default.
• W2007083491 hasConcept C2778371730 @default.
• W2007083491 hasConcept C2780801004 @default.
• W2007083491 hasConcept C2780868878 @default.
• W2007083491 hasConcept C2781034427 @default.
• W2007083491 hasConcept C2781074509 @default.
• W2007083491 hasConcept C71924100 @default.
• W2007083491 hasConcept C86803240 @default.
• W2007083491 hasConceptScore W2007083491C159047783 @default.
• W2007083491 hasConceptScore W2007083491C159654299 @default.
• W2007083491 hasConceptScore W2007083491C203014093 @default.
• W2007083491 hasConceptScore W2007083491C22070199 @default.
• W2007083491 hasConceptScore W2007083491C2778048844 @default.
• W2007083491 hasConceptScore W2007083491C2778371730 @default.
• W2007083491 hasConceptScore W2007083491C2780801004 @default.
• W2007083491 hasConceptScore W2007083491C2780868878 @default.
• W2007083491 hasConceptScore W2007083491C2781034427 @default.
• W2007083491 hasConceptScore W2007083491C2781074509 @default.
• W2007083491 hasConceptScore W2007083491C71924100 @default.
• W2007083491 hasConceptScore W2007083491C86803240 @default.
• W2007083491 hasIssue "2" @default.
• W2007083491 hasLocation W20070834911 @default.
• W2007083491 hasLocation W20070834912 @default.
• W2007083491 hasOpenAccess W2007083491 @default.
• W2007083491 hasPrimaryLocation W20070834911 @default.
• W2007083491 hasRelatedWork W1991457992 @default.
• W2007083491 hasRelatedWork W2104152050 @default.

• next